Journal of Cancer Research and Therapeutics

ORIGINAL ARTICLE
Year
: 2014  |  Volume : 10  |  Issue : 7  |  Page : 150--154

A comparison of consistency of detecting BRAF gene mutations in peripheral blood and tumor tissue of nonsmall-cell lung cancer patients


Meiyu Fang1, Chunwei Xu2, Jie Wu3, Yuping Zhang4, Chao He5 
1 Department of Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058; Department of Integrated Chinese Traditional Medicine and Wesern Medicine, Zhejiang Cancer hospital, Hangzhou, Zhejiang 310021, China
2 Department of Pathology, The General Military Hospital of Beijing PLA, Beijing 100700, China
3 Department of Surgery, Zhejiang Cancer hospital, Hangzhou, Zhejiang 310021, China
4 Department of Pathology, Shandong Weifang People's Hospital, Weifang, Shandong 261041, China
5 Department of Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, China

Correspondence Address:
Chao He
Department of Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058
China

Objective: The aim was to detect the consistency of the BRAF gene mutation in peripheral blood and tumor tissue of patients with nonsmall-cell lung cancer and discuss the clinical application value of BRAF gene mutation in peripheral blood. Materials and Methods: Real-time fluorescent quantitative polymerase chain reaction was used to test the tissues in 257 patients of nonsmall-cell lung cancer (NSCLC) and the peripheral blood samples in 318 patients of NSCLC, of which 185 cases of peripheral blood specimens could match the tissue samples, and detected the BRAF gene mutation in them by comparison of mutations consistency in blood and tissue samples, and analyzed the correlation between BRAF gene mutations and clinical characteristics of patients. Results: The BRAF gene mutation rate was 7.23% in peripheral blood of 23 patients with nonsmall-cell lung cancer, and was 5.45% in 14 cancer tissues, the mutation consistency was 80.00% in peripheral blood-tumor tissue matched samples. The consistency was statistically significant (k =0.710, P = 0.000). Conclusion: The consistency of the BRAF gene mutation in peripheral blood and tissue is high. BRAF gene mutations of peripheral blood could be used for clinical diagnosis and treatment in cases when tissue specimen is hard to get.


How to cite this article:
Fang M, Xu C, Wu J, Zhang Y, He C. A comparison of consistency of detecting BRAF gene mutations in peripheral blood and tumor tissue of nonsmall-cell lung cancer patients.J Can Res Ther 2014;10:150-154


How to cite this URL:
Fang M, Xu C, Wu J, Zhang Y, He C. A comparison of consistency of detecting BRAF gene mutations in peripheral blood and tumor tissue of nonsmall-cell lung cancer patients. J Can Res Ther [serial online] 2014 [cited 2022 May 18 ];10:150-154
Available from: https://www.cancerjournal.net/article.asp?issn=0973-1482;year=2014;volume=10;issue=7;spage=150;epage=154;aulast=Fang;type=0